Tyra Biosciences, Inc. TYRA Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s accrued expenses?
- Tyra Biosciences, Inc. (TYRA) reported accrued expenses of $15.13M in Q1 2026.
- How has Tyra Biosciences, Inc.'s accrued expenses changed year-over-year?
- Tyra Biosciences, Inc.'s accrued expenses increased by 33.6% year-over-year, from $11.32M to $15.13M.
- What is the long-term trend for Tyra Biosciences, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s accrued expenses has grown at a 73.3% compound annual growth rate (CAGR), from $1.05M to $16.44M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.